AstraZeneca gets CDSCO Panel nod to study Budesonide, Glycopyrronium and Formoterol Fumarate Dr. Divya Colin20 Oct 2024 5:45 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal for Tozorakimab Study Dr. Divya Colin13 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved AstraZeneca's...
CDSCO Panel Approves AstraZeneca's Protocol Amendment proposal for COPD drug Tozorakimab Dr. Divya Colin5 Sept 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the clinical trial...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study anti-cancer Drug Capivasertib Dr. Divya Colin28 July 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved AstraZeneca's...
CDSCO Panel Approves AstraZeneca pharma's Protocol Amendment proposal to study Anifrolumab Dr. Divya Colin1 July 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel approves AstraZeneca Pharma's Benralizumab solution for Injection in auto-injector Dr. Divya Colin1 Jun 2024 6:00 PM ISTNew Delhi: Granting the local phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Gets CDCSO Panel Nod to Import, market Eculizumab to treat Paroxysmal Nocturnal Hemoglobinuria Dr. Divya Colin29 April 2024 6:00 PM ISTNew Delhi: Noting that there is an unmet medical need in India, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit analysis of clinical data of Asian, Indian Population: CDSCO Panel Tells AstraZeneca on Durvalumab Dr. Divya Colin13 April 2024 6:00 PM ISTNew Delhi: In response to the drug major AstraZeneca's proposal for the approval of additional indication of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL...
CDSCO Panel grants AstraZeneca's proposal for withdrawing specific Indications of Olaparib Tablets Dr. Divya Colin11 April 2024 6:00 PM ISTNew Delhi: Reviewing the Clinical evidence presented by drug major AstraZeneca, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For COPD Drug Study Dr. Divya Colin5 April 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
AstraZeneca Ultomiris gets USFDA approval for adults with neuromyelitis optica spectrum disorder Ruchika Sharma26 March 2024 12:52 PM ISTUltomiris, a long-acting C5 complement inhibitor, provides immediate, complete and sustained complement inhibition.
